Antihyperalgesic Effect of the GABAALigand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic Study

Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite

(2010) Julien Déglon et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

(2010) JR Atack et al.   JOURNAL OF PSYCHOPHARMACOLOGY

HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain

(2010) Alessandra Di Lio et al.   NEUROPHARMACOLOGY

Subtype-selective GABAA receptor mimetics—novel antihyperalgesic agents?

(2009) Hanns Ulrich Zeilhofer et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

GABAergic analgesia: new insights from mutant mice and subtype-selective agonists

(2009) Hanns Ulrich Zeilhofer et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets

(2009) Gordon Munro et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

GABAAReceptor Subtype-Selective Efficacy: TPA023, an α2/α3 Selective Non-sedating Anxiolytic and α5IA, an α5 Selective Cognition Enhancer

(2008) John R. Atack   CNS Neuroscience & Therapeutics

Reversal of pathological pain through specific spinal GABAA receptor subtypes

(2008) Julia Knabl et al.   NATURE

Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice

(2008) Julia Knabl et al.   PAIN

Loss of glycinergic and GABAergic inhibition in chronic pain—contributions of inflammation and microglia

(2007) Hanns Ulrich Zeilhofer   INTERNATIONAL IMMUNOPHARMACOLOGY